approval
saveVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalCARIPRAZINE HYDROCHLORIDE — FDA approvalDec 16, 2025 · 292d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalNov 22, 2024 · 681d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 16, 2022 · 1388d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalMay 24, 2019 · 2690d ago
same company · ±60 days · 6
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalNov 21, 2018
- approvaladalimumab: HUMIRA (ADALIMUMAB) — FDA approvalDec 6, 2018
- approvaladalimumab: HUMIRA (ADALIMUMAB) — FDA approvalOct 16, 2018
- approvaladalimumab: HUMIRA (ADALIMUMAB) — FDA approvalJan 11, 2019
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalJan 25, 2019
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalJan 25, 2019
comments(0)
5-min edit window · permanent after that